doi:10.16139/j.1007-9610.2018.05.020

[1] Chen W, Zheng R, Baade PD, et al.Cancer statistics in China, 2015[J]. CA Cancer J Clin,2016,66(2):115-132.
[2] Iqbal J, Ginsburg O, Rochon PA, et al.Differences in breast cancer stage at diagnosis and cancer-specific survival by race and ethnicity in the United States[J]. JAMA,2015,313(2):165-173.
[3] Fisher B, Gunduz N, Coyle J, et al.Presence of a growth-stimulating factor in serum following primary tumor removal in mice[J]. Cancer Res,1989,49(8):1996-2001.
[4] Hellman S, Weichselbaum RR.Oligometastases[J]. J Clin Oncol,1995,13(1):8-10.
[5] Weichselbaum RR, Hellman S.Oligometastases revisited[J]. Nat Rev Clin Oncol,2011,8(6):378-382.
[6] Milano MT, Katz AW, Schell MC, et al.Descriptive analy-sis of oligometastatic lesions treated with curative-intent stereotactic body radiotherapy[J]. Int J Radiat Oncol Biol Phys,2008,72(5):1516-1522.
[7] Khan SA, Stewart AK, Morrow M.Does aggressive local therapy improve survival in metastatic breast cancer?[J]. Surgery,2002,132(4):620-627.
[8] Babiera GV, Rao R, Feng L, et al.Effect of primary tumor extirpation in breast cancer patients who present with stageⅣ disease and an intact primary tumor[J]. Ann Surg Oncol,2006,13(6):776-782.
[9] Gnerlich J, Jeffe DB, Deshpande AD, et al.Surgical removal of the primary tumor increases overall survival in patients with metastatic breast cancer: analysis of the 1988-2003 SEER data[J]. Ann Surg Oncol,2007,14(8):2187-2194.
[10] Cady B, Nathan NR, Michaelson JS, et al.Matched pair analyses of stage IV breast cancer with or without resection of primary breast site[J]. Ann Surg Oncol,2008,15(12):3384-3395.
[11] Ruiterkamp J, Ernst MF, van de Poll-Franse LV, et al. Surgical resection of the primary tumour is associated with improved survival in patients with distant metastatic breast cancer at diagnosis[J]. Eur J Surg Oncol,2009, 35(11):1146-1151.
[12] Thomas A, Khan SA, Chrischilles EA, et al.Initial surgery and survival in stage Ⅳ breast cancer in the United States, 1988-2011[J]. JAMA Surg,2016,151(5):424-431.
[13] Choi SH, Kim JW, Choi J, et al.Locoregional treatment of the primary tumor in patients with de novo Stage Ⅳ breast cancer: a radiation oncologist's perspective[J]. Clin Breast Cancer,2017,18(2):e167-e178.
[14] Harris E, Barry M, Kell MR.Meta-analysis to determine if surgical resection of the primary tumour in the setting of stage IV breast cancer impacts on survival[J]. Ann Surg Oncol,2013,20(9):2828-2834.
[15] Badwe R, Hawaldar R, Nair N, et al.Locoregional treatment versus no treatment of the primary tumour in metastatic breast cancer: an open-label randomised controlled trial[J]. Lancet Oncol,2015,16(13):1380-1388.
[16] Fitzal F, Bjelicradisic V, Knauer M, et al. Impact of breast surgery in primary metastasized breast cancer: outcomes of the prospective randomized phase Ⅲ ABCSG-28 POSYTIVE trial[J]. Ann Surg,2018-04-24[Epub ahead of print].
[17] Soran A, Ozmen V, Ozbas S, et al.Randomized trial comparing resection of primary tumor with no surgery in stage Ⅳ breast cancer at presentation: protocol MF07-01[J]. Ann Surg Onco,2018,13(Suppl 1):1-9.
[18] Lu S, Wu J, Fang Y, et al.The impact of surgical excision of the primary tumor in stage IV breast cancer on survival: a meta-analysis[J]. Oncotarget,2018,9(14):11816-11823.
[19] Shien T, Nakamura K, Shibata T, et al.A randomized controlled trial comparing primary tumour resection plus systemic therapy with systemic therapy alone in metastatic breast cancer (PRIM-BC): Japan Clinical Oncology Group Study JCOG1017[J]. Jpn J Clin Oncol,2012,42(10):970-973.
[20] Le Scodan R, Stevens D, Brain E, et al.Breast cancer with synchronous metastases: survival impact of exclusive locoregional radiotherapy[J]. J Clin Oncol,2009,27(9):1375-1381.
[21] Mauro GP, de Andrade Carvalho H, Stuart SR, et al. Effects of locoregional radiotherapy in patients with metastatic breast cancer[J]. Breast,2016,28:73-78.
[22] Cardoso F, Senkus E, Costa A, et al.4th ESO-ESMO International Consensus Guidelines for advanced breast cancer (ABC 4)[J]. Ann Oncol,2018,29(8):1634-1657.
[23] Steinauer K, Gross MW, Huang DJ, et al.Radiotherapy in patients with distant metastatic breast cancer[J]. Ra-diat Oncol,2014,9:126.
[24] Meimarakis G, Rüttinger D, Stemmler J, et al.Prolonged overall survival after pulmonary metastasectomy in patients with breast cancer[J]. Ann Thorac Surg,2013,95(4):1170-1180.
[25] Chua TC, Saxena A, Liauw W, et al.Hepatic resection for metastatic breast cancer: a systematic review[J]. Eur J Cancer,2011,47(15):2282-2290.
[26] Nanji S, Cleary S, Ryan P, et al.Up-front hepatic resection for metastatic colorectal cancer results in favorable long-term survival[J]. Ann Surg Oncol,2013,20(1):295-304.
[27] Tasleem S, Bolger JC, Kelly ME, et al. The role of liver resection in patients with metastatic breast cancer: a systematic review examining the survival impact[J]. Ir J Med Sci,2018-02-01 [Epub ahead of print].
[28] Hong TS, Wo JY, Mcdonnell EI, et al.A single arm phase 2 study of individualized proton-based stereotactic body radiation therapy (P-SBRT) of liver metastases[J]. Int J Radiat Oncol Biol Phys,2015,93(3):S112.
[29] Scorsetti M, Comito T, Tozzi A, et al.Final results of a phase Ⅱ trial for stereotactic body radiation therapy for patients with inoperable liver metastases from colorectal cancer[J]. J Cancer Res Clin Oncol,2015,141(3):543-553.
[30] Yoshimoto M, Tada K, Nishimura S, et al.Favourable long-term results after surgical removal of lung metastases of breast cancer[J]. Breast Cancer Res Treat,2008, 110(3):485-491.
[31] Planchard D, Soria JC, Michiels S, et al.Uncertain benefit from surgery in patients with lung metastases from breast carcinoma[J]. Cancer,2004,100(1):28-35.
[32] Friedel G, Pastorino U, Ginsberg RJ, et al.Results of lung metastasectomy from breast cancer: prognostic criteria on the basis of 467 cases of the international registry of lung metastases[J]. Eur J Cardiothorac Surg,2002,22(3):335-344.
[33] Rusthoven KE, Kavanagh BD, Burri SH, et al.Multi-institutional phase Ⅰ/Ⅱ trial of stereotactic body radiation therapy for lung metastases[J]. J Clin Oncol,2009,27(10):1579-1584.
[34] Hof H, Hoess A, Oetzel D, et al.Stereotactic single-dose radiotherapy of lung metastases[J]. Strahlenther Onkol,2007,183(12):673-678.
[35] Patchell RA, Tibbs PA, Walsh JW, et al.A randomized trial of surgery in the treatment of single metastases to the brain[J]. N Engl J Med,1990,322(8):494-500.
[36] Patchell RA, Tibbs PA, Regine WF, et al.Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial[J]. JAMA,1998,280(17):1485-1489.
[37] Vecht CJ, Haaxma-Reiche H, Noordijk EM, et al.Treatment of single brain metastasis: radiotherapy alone or combined with neurosurgery?[J]. Ann Neurol,1993,33(6):583-590.
[38] Noordijk EM, Vecht CJ, Haaxma-Reiche H, et al.The choice of treatment of single brain metastasis should be based on extracranial tumor activity and age[J]. Int J Radiat Oncol Biol Phys,1994,29(4):711-717.
[39] Brown PD, Ballman KV, Cerhan JH, et al.Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trial[J]. Lancet Oncol,2017,18(8):1049-1060.

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	. [J]. Journal of Surgery Concepts & Practice, 2022, 27(05): 385-386.
[2]	. [J]. Journal of Surgery Concepts & Practice, 2022, 27(05): 387-391.
[3]	. [J]. Journal of Surgery Concepts & Practice, 2022, 27(05): 392-395.
[4]	. [J]. Journal of Surgery Concepts & Practice, 2022, 27(05): 396-402.
[5]	. [J]. Journal of Surgery Concepts & Practice, 2022, 27(05): 403-405.
[6]	. [J]. Journal of Surgery Concepts & Practice, 2022, 27(05): 406-410.
[7]	. [J]. Journal of Surgery Concepts & Practice, 2022, 27(05): 411-415.
[8]	. [J]. Journal of Surgery Concepts & Practice, 2022, 27(05): 416-420.
[9]	YANG Cuiyan, WANG Haoyu, CHEN Xiaosong, SHEN Kunwei. Study on tumour suppressor gene TP53 mutation and prognosis in patients with triple-negative breast cancer [J]. Journal of Surgery Concepts & Practice, 2022, 27(05): 421-428.
[10]	PAN Ruixin, CHEN Xiaosong, SHEN Kunwei. Study on circulating tumor DNA and circulating tumor cell detecting minimal residual disease in breast cancer [J]. Journal of Surgery Concepts & Practice, 2022, 27(05): 463-467.
[11]	ZHU Siyi, CHEN Xiaosong, SHEN Kunwei. Study on obesity associated with prognosis of early breast cancer and efficacy of adjuvant therapy [J]. Journal of Surgery Concepts & Practice, 2022, 27(05): 468-472.
[12]	WANG Jieqiang, MA Dekui. Study on trophoblast cell-surface antigen 2 gene and triple-negative breast cancer [J]. Journal of Surgery Concepts & Practice, 2022, 27(05): 473-477.
[13]	LIU Miao, SHEN Yan, FU Xiaohong, HU Jiaojiao, CHEN Qingqing, YING Tao. A comparative study on breast cancer between smaller and larger diameters using conventional ultrasound and contrast-enhanced ultrasound [J]. Journal of Surgery Concepts & Practice, 2022, 27(3): 229-233.
[14]	CHEN Yuanyuan, YE Xin, TANG Yongzhe, WANG Jie, HE Qi. Prognosis of invasive micropapillary carcinoma versus invasive ductal carcinoma of the breast: a comparative analysis after propensity score matching [J]. Journal of Surgery Concepts & Practice, 2021, 26(04): 353-360.
[15]	CHEN Xiaosong, LI Shuai, WU Jiayi, HUANG Ou, CHAI Weimin, YAO Jiejie, ZHU Ying, XU Chen, CHEN Jiayi, QU Qing, FEI Xiaochun, DING Xiaoyi, LIN Lin, ZHANG Nan, FANG Qiong, HE Jianrong, ZHU Li, LI Yafen, CHEN Weiguo, SHEN Kunwei. Diagnosis, treatment and survival of breast cancer patients in single large hospital: a 10-year analysis [J]. Journal of Surgery Concepts & Practice, 2021, 26(02): 149-158.